Clinical and Biological Evaluation of the Novel Cd30/Cd16a Tetravalent Bispecific Antibody (Afm13) in Relapsed or Refractory Cd30-Positive Lymphoma With Cutaneous Presentation: A Biomarker Phase Ib/Iia Study (Nct03192202)

Hematological Oncology - United Kingdom
doi 10.1002/hon.123_2630

Related search